QAV Investing Podcast (Free Edition)

In the first half of this episode we're joined by Navarre Trousselot & Thom Benny from Navexa, an online portfolio platform, who tell us a bit about the vision for their product and what they've seen investors doing lately. Then we talk about minimising brokerage fees, building a portfolio with lump sums, the 3PTL on VDGR, Tony's latest thinking about commodity sell lines, how to deal with st...

We talk about the bank results; tech wreck; Buffett breaking the NASDAQ; Increasing Net Equity v NEPS; re-naming the “buy list”; LICS and NTA; Price to Operating Cashflow for ETFs; Tony’s performance today vs when he had a smaller portfolio; CCV’s buy line; where the Top 200 ASX stocks came from; graphic positive sentiment for see-saw stocks; the gold cycle; and ATL’s debt levels.

This week we recorded while I was staying with Tony down at Cape Schanck! We talked about the collapse of BPT, why ATL is our SOTW,  the highlights of the Berkshire Hathaway 2021 AGM, the importance of price to cashflow in our checklist, Stock Doctor's coverage of A2 Milk, why companies issue new shares at a steep discount, MML's 3PTL buy line, gold miners and market cycles, why BOQ dropped off th...

On this episode, we talk about our portfolio performance, SOTW, Colin Nicholson’s three market stages, Jack Bogle’s fourth law of motion, if SSG is a sell, the value of private banking, the idea of using increasing equity per share, and investing in Early Stage Innovation Companies.

This week we chat with Chris Stott, Chief Investment Officer at 1851 Capital and then get into our regular show, where we discuss the MRC collapse, the CAA takeover bid, Geoff Wilson’s LIC strategy, our SOTW (DSK), if MYR is close to a sell, DKM dropping off the buy list, directors transactions, IV2 challenger strategy, why research firms suspend coverage on stocks, using (ATR) average true range...

Regression testing with Dylan the intern; “A Quantitative Approach to Tactical Asset Allocation”; SOTW: MXI; Tony’s thoughts on investing in a NASDAQ 100 ETF; should keep our AGD shares; Why did TK skip past MYR on the buy list; capital raising only to institutional investors; How AGMs fit into Tony's investment strategy; looking at a Depth of a share chart; postponing a decision to buy a share ba...

Ray Dalio on BTC. Lou Simpson’s investing philosophy. The proposed TLS break-up. Selling low dividend payers. Tolerance for older data. KRMs health score. 3PTL for ADH, HLA & HVN. Tony's view on the Iron trend line. Replacing IV1 and IV2 with PE ratios.

This week: MRC firing their CEO and the price dropped 25% - why didn't we sell?; Lincoln fund results; ASA webinar by James Holt; WAAAX performance 20/21; CVL down 13% since we bought it; MAH groundhog; Flitman model is out; red flags for companies that might go into a trading halt; why share prices fall after they go ex dividend; how TK decides what to sell when he needs to take cash out of his p...

Selling BEN; calculating portfolio performance; stocks being removed from an index; companies with just six months of data; timing of a new 3pt upturn; share buy backs; DPS vs EPS; qualified audits; Vocus (VOC) takeover; highest QAV scores for ASX200; "GOLDEN CROSS" and "DEATH CROSS”; company notices; balancing out tax payable on portfolio gains.

Workshops; Lemmings; CBA launches BNPL service; CVL below the buy price; STOW = GCY; ZIM audit unsplatted; How Tony decided to sell a stock before the 3PTL; Should we fudge the ECX sell line; EVZ qualified audit; what metrics make up the SD IV; where Tony learnt how to draw 3PTL; gold price chart on index mundi; how the chi x works with or along side the asx.

The 2021 Buffett newsletter; Why we sold HAW & RMS; how important is negative EPS; the impact of unlisted share options; the high prices of the banking sector; Tony’s thoughts on Dividend reinvestment plans; and Tony’s thoughts on investing through high inflation or high interest rate environments such as the 1980s.

Our guest on this episode is American investor David Waldron, author of "Build Wealth With Common Stocks", a great, new introduction to value investing.

Selling HAW. GME lawsuit. Changes to disclosure law. Stock of the week. Return on Equity as a metric. Greater portfolio allocation for higher QAV scores. Trendline buffers. Manually entered scores. BOQ / ME merger. MXI qualified audit. MQG Capital Notes 5 raise. Selling “overvalued” stocks.

The Kohler Effect. Broker Speak. ETF surge. Rudi on Value. The "Buffett indicator”. Stock of the week - BOQ. On market share buyback facilities. GDG and Pooled Development Fund (PDF). Reporting season patterns. MSV impairment announcement. Last Period Analysed column. KRM care and maintenance. VUK sell line.

This is the audio from our 4th Zoom call recorded 9 Feb 2021.

On this episode: GME update; BNPL stocks to be regulated in the UK; Roger Montgomery says there’s no ASX bubble; Stock Doctor commodity pricing; NCK is TK’s Stock of the Week; our portfolio EOM report; VUK cashflow; investing based on commodity prices; if TK would use options; what TK would do if there were two stocks with with similar scores; and is a buy/sell activated if price crosses over the...

Hedge funds v Reddit. Ray Dalio on Bitcoin. Tony’s journal entries. Portfolio update. Regression testing Tobias Carlisle. TK's "war stories" of the '99/'00 bubble. CCV 3PTL Sentiment. KRM coming out the naughty corner. SD cashflow. Index Mundi data dates.

This week: ASX lower on fears of US bubble. Howard Marks' capitulation. Ray Dalio's thoughts on a coming US civil war. Using Gross Revenue Growth per Share to value "growth" stocks. Stock of the week - KRM. Using a logarithmic price scale. Tony's thoughts on the Blue-Chippers in the ASX. Determining 'Consistently Increasing Equity'. Defining 'recent positive upturn'. Reasons to sell. NTD and the A...

In our first episode of 2021, we review our portfolio's CY20 performance; margin loan rates; What TK does on a daily/weekly basis for managing his portfolio; relative QAV performance of large vs mid vs small cap companies; the 'minimum' amount of stock someone just getting started should buy; fudging ECX and VUK; whether or not we should rebalance every so often; Tony’s views on CSL; the recent dr...

This is my highlight show for 2020. Obviously, from an investing perspective, 2020 was all about how to handle Australia's first recession in 30 years and a major market correction, so I've pulled together some of Tony's comments on those subjects in the first half of the year. To finish off the episode, I picked a couple of clips of TK talking about the miracle of compounding and why investors ne...

Our guest on our final episode for 2020 is QAV Club member Damien Parker. He joined us recently to chat about his investing and business career. After a successful career in accounting and a failed property development business, Damien bounced back to write 30 business programs/manuals which grossed $50 million - and created Positive Business, the longest-running newsletter to the small-medium bus...

Last week’s jump in HAW demonstrates why we don’t sell until something hits the 3PTL. Would Tony buy still FMG today? What are the risks of buying stocks with margin loans? Can we fudge the COVID cough? Should we try to predict the future? What about MLD’s capital raising? What happened with MSV? All this and Day Of The Triffids on our last episode for 2020!

Is value investing back? Yes, according to the same people who reported it was dead last year. On this week’s episode we talk about Tony’s “Stock Of The Year”, why we use different Intrinsic Value calculations, whether or not WBC is a buy, whether or not stock consolidations are something to worry about, how Tony uses stop losses, whether or not we should only buy stocks with a significant directo...

Can we ignore the COVID cough in our 3PTL charts? What do you do when you own stock in a delisted company? How would we treat Depreciation when thinking about CCP? Does a capital raise cause a bump in the price? Should we listen to Ray Dalio on diversification? Why did Tony buy SFR and not any of the stocks on the Buy list with a much higher QAV score? Should we add a ‘one-month up turn’ to the ch...